Solid-phase combinatorial synthesis of a Lysyl-tRNA Synthetase (LysRS) inhibitory library

Journal of Combinatorial Chemistry

Volumn 10, Issue 3, 2008, Pages 391-400

  Farrera Sinfreu, Josep ^a   Español, Yaiza ^a   Geslain, Renaud ^a   Guitart, Tanit ^a   Albericio, Fernando ^a   De Pouplana, Lhrís Ribas ^a,b   Royo, Miriam ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; DRUG DERIVATIVE; LYSINE TRANSFER RNA LIGASE; PROLINE;

AMINOACYLATION; ANIMAL; ARTICLE; CHEMISTRY; COMBINATORIAL CHEMISTRY; CONFORMATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; ENZYMOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; METHODOLOGY; STEREOISOMERISM; SYNTHESIS; TRYPANOSOMA BRUCEI;

AMINOACYLATION; ANIMALS; ANTIPROTOZOAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG EVALUATION, PRECLINICAL; LYSINE-TRNA LIGASE; MOLECULAR CONFORMATION; PROLINE; STEREOISOMERISM; TRYPANOSOMA BRUCEI BRUCEI;

EID: 45149109605     PISSN: 15204766     EISSN: None     Source Type: Journal    
DOI: 10.1021/cc700157j     Document Type: Article

References (52)

1. Hayes, J. D.; Wolf, C. R. Biochem. J. 1990, 272, 281-295.
2. Baquero, F. J. Antimicrob. Chemother. 1997, 39, A1-6.
3. (a) Schimmel, P.; Tao, J.; Hill, J. FASEB J. 1998, 12, 1599-1609.
4. (b) Kim, S.; Lee, S. W.; Choi, E.-C.; Choi, S. Y. Appl. Microbiol. Biotechnol. 2003, 61, 278-288.
5. Tao, J.; Schimmel, P. Expert Opin. Investig. Drugs 2000, 9 (8), 1767-1775.
6. Tan, T. H. P.; Pach, R.; Crausaz, A.; Ivens, A.; Schneider, A. Mol. Cell. Biol. 2002, 22 (11), 3707-3717.
7. Woese, C. R.; Olsen, G. J.; Ibba, M.; Soll, D. Microbiol Mol. Biol. Rev. 2000, 64 (1), 202-236.
8. (a) Fuller, A. T.; Mellows, G.; Woolford, M.; Banks, G. T.; Barrow, K. D.; Chain, E. B. Nature (London) 1971, 234, 416-417.
9. (b) Casewell, M. W.; Hill, R. L. R. J. Antimicrob. Chemother. 1985, 15, 523-531.
10. (c) Hughes, J.; Mellows, G. Biochem. J. 1980, 191, 209-219.
11. Ochsner, U. A.; Sun, X.; Jarvis, I.; Critchley, I.; Janjic, N. Expert Opin. Investig. Drugs 2007, 16 (5), 573-593.
12. (a) Heacock, D.; Forsyth, C. J.; Shiba, K.; Musiter-Forsyth, K. Bioorg. Chem. 1996, 24, 273-289.
13. (b) Forrest, A. K.; Jarvest, R. L.; Mensah, L. M.; O'Hanlon, P. J.; Pope, A. J.; Sheppard, R. J. Bioorg. Med. Chem. Lett. 2000, 10, 1871-1874.
14. (c) Yu, X. Y.; Hill, J. M.; Yu, G.; Wamg, W.; Kluge, A. F.; Wendler, P.; Gallant, P. Bioorg. Med. Chem. Lett. 1999, 9, 375-380.
15. (d) Kim, S. E.; Kim, S. Y.; Kim, S.; Kang, T.; Lee, J. Bioorg. Med. Chem. Lett. 2005, 15, 3389-3393.
16. (e) Balg, C.; Blais, S. P.; Bernier, S.; Huot, J. L.; Couture, M.; Lapinte, J.; Chenevert, R. Bioorg. Med. Chem. 2007, 15, 295-304.
17. Nass, G.; Poralla, K.; Zahner, H. Biochem. Biophys. Acta 1969, 34, 84-91.
18. Paetz, W.; Nass, G. Eur. J. Biochem. 1973, 35, 331-337.
19. Tanaka, K.; Tamoki, M.; Watanabe, S. Biochem. Biophys. Acta 1969, 195, 244-245.
20. Ogilvie, A.; Wiebauer, K.; Kersten, W. Biochem. J. 1975, 152, 511-515.
21. Werner, R. G.; Thorpe, L. F.; Reuter, W.; Nierhaus, K. H. Eur. J. Biochem. 1976, 68, 1-3.
22. Konrad, I.; Roschenthaler, R. FEBS Lett. 1977, 83, 341-347.
23. Konishi, M.; Nishio, M.; Saitoh, K.; Miyaki, T.; Oki, T.; Kawaguchi, H. J. Antibiot. (Tokyo) 1989, 42, 1749-1755.
24. Lee, J.; Kang, S. U.; Kim, S. Y.; Kim, S. E.; Jo, Y. J.; Kim, S. Bioorg. Med. Chem. Lett. 2001, 11, 965-968.
25. (a) Brown, P.; Eggleston, D. S.; Haltiwanger, R. C.; Jarvest, R. L.; Mensah, L.; O'Hanlon, P. J.; Pope, A. J. Bioorg. Med. Chem. Lett. 2001, 11, 711-714.
26. (b) Berge, J. M.; Copley, R. C.; Eggleston, D. S.; Hamprecht, D. W.; Jarvest, R. L.; Mensah, L. M.; O'Hanlon, P. J.; Pope, A. J. Bioorg. Med. Chem. Lett. 2000, 10, 1811-1814.
27. Parr, I.; Hill, J.; Finn, J.; Yang, D.; Silverman, J.; Oliver, N.; Gallant, P.; Mak, E.; Stein, R.; Lim, A. Proceedings of the 41st Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, 2001.
28. (a) Cubist Pharmaceuticals Inc. U.S. Patent 5,726,195, 1998.
29. (b) Cubist Pharmaceuticals Inc. Intl. Patent WO 98/41215, 1998.
30. SmithKline Beecham PLC Intl. Patent WO 00/21949, 2000.
31. Ibba, M.; Soll, D. Annu. Rev. Biochem. 2000, 69, 617-50.
32. Desogus, G.; Todone, F.; Brick, P.; Onesti, S. Biochemistry 2000, 39, 8418-8425.
33. (a) Brown, P.; Richardson, C. M.; Mensah, L. M.; O'Hanlon, P. J.; Osborne, N. F.; Pope, A. J.; Walker, G. Bioorg. Med. Chem. 1999, 7, 2473-2485.
34. (b) Brown, M. J. B.; Mensah, L. M.; Doyle, M. L.; Broom, N. J. P.; Osbourne, N.; Forrest, A. K.; Richardson, C. M.; O'Hanlon, P. J.; Pope, A. J. Biochemistry 2000, 39, 6003-6011.
35. (c) Belrhali, H.; Yaremchuk, A.; Tukalo, M.; Larsen, K.; Berthet-Colominas, C.; Leberman, R.; Beijer, B.; Sproat, B.; Als-Nielsen, J.; Grübel, G.; Legrand, J.-F.; Lehmann, M.; Cusack, S. Science 1994, 263, 1432-1436.
36. (d) Winum, J.-Y.; Scozzafava, A.; Montero, J.-L.; Supuran, C. T. Med. Res. Rev. 2005, 25 (2), 186-228.
37. (a) Lee, J.; Kang, S. U.; Kang, M. K.; Chun, M. W.; Jo, Y. J.; Kwak, J. H.; Kim, S. Bioorg. Med Chem. Lett. 1999, 9, 1365-1370.
38. (b) Lee, J.; Kang, S. U.; Kim, S. Y.; Kim, S. E.; Kang, M. K.; Jo, Y. J.; Kim, S. Bioorg. Med. Chem. Lett. 2001, 11, 961-964.
39. Chan, W. C.; Mellor, S. L.; Atkinson, G. E. In Solid-Phase Organic Syntheses; Czarnik, Anthony W., Ed.; John Wiley and Sons:New York, 2001; pp 85-99.
40. (a) Kuisle, O.; Quinoa, E.; Riguera, R. J. Org. Chem. 1999, 64, 8063-8075.
41. (b) Vergnon, A. L.; Pottorf, R. S.; Player, M. R. J. Comb. Chem. 2004, 6, 91-98.
42. Mellor, S. L.; McGuire, C.; Chan, W. C. Tetrahedron Lett. 1997, 38, 3311-3314.
43. In the case of hydroxyproline, the hydroxyl group was maintained free. The use of the alcohol-protected hydroxyproline with this resin was discarded because in a control cleavage after deprotection of THP with p-toluensulfonic acid, the target compound 1b{1} was not detected, probably because of the premature compound cleavage.
44. Farrera-Sinfreu, J.; Albericio, F.; Royo, M. J. Comb. Chem. 2007, 9, 501-506.
45. Kim, M. G.; Jung, J. C.; Sung, M. J.; Choi, Y. K.; An, S. G.; Lee, S.-J.; Yoon, G.-J.; Park, M. H. Bioorg. Med. Chem. Lett. 1996, 6 (17), 2077-2080.
46. Farrera-Sinfreu, J.; Zaccaro, L.; Vidal, D.; Salvatella, X.; Giralt, E.; Pons, M.; Albericio, F.; Royo, M. J. Am. Chem. Soc. 2004, 126, 6048-6057.
47. Farrera-Sinfreu, J.; Giralt, E.; Castel, S.; Albericio, F.; Royo, M. J. Am. Chem. Soc. 2005, 127, 9459-9468.
48. Mans, R. J.; Novelli, G. D. Arch. Biochem. Biophys. 1961, 94, 48-53.
49. Ataide, S. F.; Ibba, M. Biochemistry 2004, 43 (37), 11836-41.
50. Rajeswaran, W. G.; Hocart, S. J.; Murphy, W. A.; Taylor, J. E.; Coy, D. H. J. Med. Chem. 2001, 44, 1416-1421.
51. Erchegyi, J.; Hoeger, C. A.; Low, W.; Hoyer, D.; Waser, B.; Eltschinger, V.; Schaer, J.-C.; Cescato, R.; Reubi, J. C.; Rivier, J. E. J. Med. Chem. 2005, 48, 507-514.
52. Yraola, F.; Ventura, R.; Vendrell, M.; Colombo, A.; Fernandez, J.-C.; De La Figuera, N.; Fernandez-Forner, D.; Royo, M.; Forns, P.; Albericio, F. QSAR, Comb. Sci. 2004, 23, 145-152.